Literature DB >> 8575774

Human gastric inhibitory polypeptide receptor: cloning of the gene (GIPR) and cDNA.

Y Yamada1, T Hayami, K Nakamura, P J Kaisaki, Y Someya, C Z Wang, S Seino, Y Seino.   

Abstract

Gastric inhibitory polypeptide (GIP), which is released from the gastrointestinal tract, stimulates insulin secretion from pancreatic beta cells and plays a crucial role in the regulation of insulin secretion during the postprandial phase. We have isolated the human gene (GIPR) and cDNA encoding the GIP receptor by a combination of the conventional screening and polymerase chain reaction procedures. Human GIP receptor cDNA encodes a protein of 466 amino acids that is 81.5 and 81.2% identical to the previously cloned hamster and rat GIP receptor, respectively. Hydropathic analysis shows the presence of a signal peptide and seven potential transmembrane domains, a feature characteristic of the VIP/glucagon/secretin receptor family of G protein-coupled receptors. The human GIPR gene is about 13.8 kb long, consists of 14 exons, and carries 17 Alu repeats.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8575774     DOI: 10.1006/geno.1995.9937

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  14 in total

1.  Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice.

Authors:  K Miyawaki; Y Yamada; H Yano; H Niwa; N Ban; Y Ihara; A Kubota; S Fujimoto; M Kajikawa; A Kuroe; K Tsuda; H Hashimoto; T Yamashita; T Jomori; F Tashiro; J Miyazaki; Y Seino
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

Review 2.  The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.

Authors:  Daniela Regazzo; Mattia Barbot; Carla Scaroni; Nora Albiger; Gianluca Occhi
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

Review 3.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

4.  Cav1.2 and Cav1.3 are differentially coupled to glucagon-like peptide-1 potentiation of glucose-stimulated insulin secretion in the pancreatic beta-cell line INS-1.

Authors:  Sarah Melissa P Jacobo; Marcy L Guerra; Gregory H Hockerman
Journal:  J Pharmacol Exp Ther       Date:  2009-08-26       Impact factor: 4.030

Review 5.  Clinical utility of dipeptidyl peptidase-4 inhibitors: a descriptive summary of current efficacy trials.

Authors:  George Grunberger
Journal:  Eur J Clin Pharmacol       Date:  2014-09-02       Impact factor: 2.953

6.  Pleiotropic effects of sitagliptin in the treatment of type 2 diabetes mellitus patients.

Authors:  Akira Kubota; Hajime Maeda; Akira Kanamori; Kiyokazu Matoba; Yasuyuki Jin; Fuyuki Minagawa; Mitsuo Obana; Koutarou Iemitsu; Shogo Ito; Hikaru Amemiya; Mizuki Kaneshiro; Masahiko Takai; Hideaki Kaneshige; Kazuhiko Hoshino; Masashi Ishikawa; Nobuaki Minami; Tetsuo Takuma; Nobuo Sasai; Sachio Aoyagi; Takehiro Kawata; Atsuko Mokubo; Hiroshi Takeda; Shin Honda; Hideo Machimura; Tetsuya Motomiya; Manabu Waseda; Yoshikazu Naka; Yasushi Tanaka; Yasuo Terauchi; Ikuro Matsuba
Journal:  J Clin Med Res       Date:  2012-09-12

7.  Pleiotropic effects of GIP on islet function involve osteopontin.

Authors:  Valeriya Lyssenko; Lena Eliasson; Olga Kotova; Kasper Pilgaard; Nils Wierup; Albert Salehi; Anna Wendt; Anna Jonsson; Yang Z De Marinis; Lisa M Berglund; Jalal Taneera; Alexander Balhuizen; Ola Hansson; Peter Osmark; Pontus Dunér; Charlotte Brøns; Alena Stancáková; Johanna Kuusisto; Marco Bugliani; Richa Saxena; Emma Ahlqvist; Timothy J Kieffer; Tiinamaija Tuomi; Bo Isomaa; Olle Melander; Emily Sonestedt; Marju Orho-Melander; Peter Nilsson; Sara Bonetti; Riccardo Bonadonna; Roberto Miccoli; Stefano Delprato; Piero Marchetti; Sten Madsbad; Pernille Poulsen; Allan Vaag; Markku Laakso; Maria F Gomez; Leif Groop
Journal:  Diabetes       Date:  2011-08-01       Impact factor: 9.461

Review 8.  GIP and GLP-1, the two incretin hormones: Similarities and differences.

Authors:  Yutaka Seino; Mitsuo Fukushima; Daisuke Yabe
Journal:  J Diabetes Investig       Date:  2010-04-22       Impact factor: 4.232

9.  Factors influencing the durability of the glucose-lowering effect of sitagliptin combined with a sulfonylurea.

Authors:  Akira Kubota; Daisuke Yabe; Akira Kanamori; Akira Kuroe; Nobuo Takahashi; Tatsuhiko Saito; Ikuro Matsuba; Koichiro Nabe; Takeshi Kurose; Yutaka Seino
Journal:  J Diabetes Investig       Date:  2014-02-11       Impact factor: 4.232

10.  Transcriptional analysis of apoptotic cerebellar granule neurons following rescue by gastric inhibitory polypeptide.

Authors:  Barbara Maino; Maria Teresa Ciotti; Pietro Calissano; Sebastiano Cavallaro
Journal:  Int J Mol Sci       Date:  2014-04-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.